SCHEMBL92935

SCHEMBL92935

CCc1ccc(CO)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LPL P06858 1/20 0.52
LIPG Q9Y5X9 1/20 0.52
TP53 P04637 1/20 0.50
TSHR P16473 1/20 0.50
ALDH1A1 P00352 1/20 0.50
SMN1; SMN2 Q16637 1/20 0.48
TAAR1 Q96RJ0 1/20 0.48
PLAU P00749 1/20 0.46
CYP2A6 P11509 1/20 0.46
TRPA1 O75762 1/20 0.46
IDO1 P14902 2/20 0.44
PLK1 P53350 1/20 0.44
NOS3 P29474 1/20 0.44
NOS1 P29475 1/20 0.44
PRSS1 P07477 1/20 0.44
PRSS2 P07478 1/20 0.44
PRSS3 P35030 1/20 0.44
CHKA P35790 1/20 0.43
EGFR P00533 1/20 0.43
VHL P40337 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Methylamine SCHEMBL27945331 0.94 TAAR1 (0.50) LPLLIPGTP53TSHRALDH1A1
SCHEMBL4623255 0.92 EGFR (0.48) LPLLIPGTP53TSHRALDH1A1
SCHEMBL15468969 0.87 LPL (0.48) LPLLIPGTP53TSHRALDH1A1
Alcohol SCHEMBL27952977 0.87 LPL (0.57) LPLLIPGTP53TSHRALDH1A1
Ethylbenzene SCHEMBL2592228 0.86 TP53 (0.74) LPLLIPGTP53TSHRALDH1A1
SCHEMBL30879488 0.85 LTA4H (0.65) LPLLIPGALDH1A1SMN1; SMN2TRPA1
SCHEMBL17954218 0.85 CYP2A6 (0.52) LPLLIPGTP53TSHRALDH1A1
SCHEMBL22222995 0.83 ESR1 (0.44) LPLLIPGTP53TSHRALDH1A1
Methyl Alcohol SCHEMBL27728601 0.83 LPL (0.60) LPLLIPGTP53TSHRALDH1A1
SCHEMBL36295 0.83 TP53 (0.67) LPLLIPGTP53TSHRALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1808 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-122011050-A 2N-type cobalt complex, preparation method thereof and hydrosilylating reaction of hydrosilane and alcohol 石河子大学 2026-05-12 CN claimed
WO-2025053791-A1 ONE-POT GRAFTING OF POLYMERS FROM ALCOHOLS AND BIOMASSES NANYANG TECHNOLOGICAL UNIVERSITY (SG) 2025-03-13 WO claimed
US-20250075147-A1 FRAGRANCE AND FLAVOR COMPOSITIONS COMPRISING NEW FLAVOR AND FRAGRANCE INGREDIENTS OSMO LABS, PBC 2025-03-06 US claimed
CN-116212854-B La (La)1-xKxMnO3Perovskite preparation method and application thereof in preparing aldehyde by selectively oxidizing organic alcohol with molecular oxygen 武汉纺织大学 2024-07-05 CN claimed
CN-114394922-B Preparation method of N-substituted pyrrolyl aryl propenone compound 河南农业大学 2024-06-11 CN claimed
CN-117645906-A Organic and inorganic cleaning composition for deposition mask of organic light emitting display device 载元产业株式会社 2024-03-05 CN claimed
CN-115536883-B 2D multilayer lamellar micelle and preparation method thereof 浙江理工大学 2023-11-03 CN claimed
CN-116675858-A Preparation method of amino-terminated hyperbranched polythioether and prepared internal crosslinking modified polyurethane 扬州市祥华新材料科技有限公司 2023-09-01 CN claimed
CN-116212854-A La (La) 1-x K x MnO 3 Perovskite preparation method and application thereof in preparing aldehyde by selectively oxidizing organic alcohol with molecular oxygen 武汉纺织大学 2023-06-06 CN claimed
CN-115536883-A 2D multilayer lamellar micelle and preparation method thereof 浙江理工大学 2022-12-30 CN claimed
WO-2001077079-A2 POLYCYCLIC ARYL AND HETEROARYL SUBSTITUTED 4-PYRIDONES USEFUL FOR SELECTIVE INHIBITION OF THE COAGULATION CASCADE PHARMACIA CORPORATION (US) 2001-10-18 WO claimed
WO-2001077097-A2 POLYCYCLIC ARYL AND HETEROARYL SUBSTITUTED 4-PYRONES USEFUL FOR SELECTIVE INHIBITION OF THE COAGULATION CASCADE PHARMACIA CORPORATION (US) 2001-10-18 WO claimed
WO-2001068605-A1 POLYCYCLIC ARYL AND HETEROARYL SUBSTITUTED BENZENES USEFUL FOR SELECTIVE INHIBITION OF THE COAGULATION CASCADE PHARMACIA CORPORATION (US) 2001-09-20 WO claimed
US-20010018446-A1 Substituted N-Aliphatic-N-Aromatictertiary-Heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity G.D. SEARLE & CO. (US) 2001-08-30 US claimed
EP-1115695-A1 (R)-CHIRAL HALOGENATED 1-SUBSTITUTEDAMINO-(N+1)-ALKANOLS USEFUL FOR INHIBITING CHOLESTERYL ESTER TRANSFER PROTEIN ACTIVITY Monsanto Company (US) 2001-07-18 EP claimed
EP-1115693-A1 SUBSTITUTED POLYCYCLIC ARYL AND HETEROARYL $i(TERTIARY)-HETEROALKYLAMINES USEFUL FOR INHIBITING CHOLESTERYL ESTER TRANSFER PROTEIN ACTIVITY Monsanto Company (US) 2001-07-18 EP claimed
EP-1115694-A1 SUBSTITUTED N-ALIPHATIC-N-AROMATIC (TERTIARY)-HETEROALKYLAMINES USEFUL FOR INHIBITING CHOLESTERYL ESTER TRANSFER PROTEIN ACTIVITY Monsanto Company (US) 2001-07-18 EP claimed
WO-2000018724-A1 (R)-CHIRAL HALOGENATED 1-SUBSTITUTEDAMINO-(n+1)-ALKANOLS USEFUL FOR INHIBITING CHOLESTERYL ESTER TRANSFER PROTEIN ACTIVITY MONSANTO COMPANY (US) 2000-04-06 WO claimed
WO-2000018723-A1 SUBSTITUTED N-ALIPHATIC-N-AROMATIC TERTIARY-HETEROALKYLAMINES USEFUL FOR INHIBITING CHOLESTERYL ESTER TRANSFER PROTEIN ACTIVITY MONSANTO COMPANY (US) 2000-04-06 WO claimed
WO-2000018721-A1 SUBSTITUTED POLYCYCLIC ARYL AND HETEROARYL TERTIARY-HETEROALKYLAMINES USEFUL FOR INHIBITING CHOLESTERYL ESTER TRANSFER PROTEIN ACTIVITY MONSANTO COMPANY (US) 2000-04-06 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20010018446-A1 Substituted N-Aliphatic-N-Aromatictertiary-Heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity CETP, DBI, MTTP LPL 68/4885LIPG 28/4885TP53 4258/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.